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Abstract
Nanoparticles introduced in living cells are capable of strongly promoting the aggregation
of peptides and proteins. We use here molecular dynamics simulations to characterise in
detail the process by which nanoparticle surfaces catalyse the self-assembly of peptides into
fibrillar structures. The simulation of a system of hundreds of peptides over the millisecond
timescale enables us to show that the mechanism of aggregation involves a first phase in
which small structurally disordered oligomers assemble onto the nanoparticle and a second
phase in which they evolve into highly ordered β-sheets as their size increases.
Author Summary
Protein misfolding and aggregation are associated with a wide variety of human disorders,
which include Alzheimer’s and Parkinson’s diseases and late onset diabetes. It has been re-
cently realised that the process of aggregation may be triggered by the presence of nanoparti-
cles. We use here molecular dynamics simulations to characterise the molecular mechanism
by which such nanoparticles are capable of enhancing the rate of formation of peptide ag-
gregates. Our findings indicate that nanoparticle surfaces act as a catalyst that increases the
local concentration of peptides, thus facilitating their subsequent assembly into stable fibril-
lar structures. The approach that we present, in addition to providing a description of the
process of aggregation of peptides in the presence of nanoparticles, will enable the study of
the mechanism of action of a variety of other potential aggregation-promoting agents present
in living organisms, including lipid membranes and other cellular components.
Introduction
With the advent of nanoscience much interest has arisen about the ways in which nanopar-
ticles interact with biological systems, because of their potential applications in nanotech-
nology and effects on human health [1–7]. When nanoparticles are introduced in a living
organism they may interact with a variety of different cellular components with yet largely
unknown pathological consequences. These concerns have been articulated particularly in
the case of misfolding disorders with increasing evidence, for example, about an associa-
tion between exposure to heavy metals and an enhanced risk of developing Parkinson’s dis-
ease [8]. Such misfolding diseases are caused by the aberrant association of peptides and
proteins [9], which result in fibrillar aggregates that share a common cross-β structure of in-
tertwined layers of β-sheets [9]. Although is well known that such aggregates are formed in
a nucleation-dependent manner [9,10] and that very often nucleation phenomena are known
to be triggered by external factors [11], experimental reports on protein aggregation in het-
erogeneous systems have only begun to emerge [12–15]. These studies are important, since
peptides and proteins in vivo often interact with a variety of potential seeding agents such as
macromolecular complexes or membranes, which may strongly influence their aggregation
behaviour. Indeed, it is well known that colloids [12, 14, 15], lipid bilayers [16], and liquid-
air, liquid-solid or liquid-liquid interfaces [17, 18] can have significant effects in promoting
amyloid formation. It has also been recently shown that, in vivo, nanoparticles are often cov-
ered by peptides and proteins that determine their behaviour in the cell [13, 15]. Despite
these observations, the detailed processes underlying the association of proteins on surfaces
or nanoparticles have so far remained elusive.
In this work we use molecular dynamics simulations to investigate the molecular mecha-
nism of peptide self-assembly in the presence of spherical nanoparticles. Although computa-
tional studies using full atomistic models have provided considerable insight into the role of
fundamental forces in promoting the self-assembly of polypeptide chains, they are restricted
to relatively small systems of peptides and short timescales [19–29]. Coarse-grained models
have proven capable of following the evolution of systems composed of larger numbers of
peptides over longer timescales. The most tractable models are confined to a lattice [30–32],
although in these cases the structural details used to represent polypeptide chain conforma-
tions are necessarily limited. Off-lattice protein models used to simulate protein aggregation
include two-state models in which the protein can adopt, in addition to a native state, a state
that is prone to β-sheet formation [33, 34], two-bead models, in which each amino acid is
represented by two spheres with a knowledge-based potential [35], and fine-grained models
with explicit representation of the side chains in combination with a phenomenological force
field [36–39]. The more detailed is the protein model, the higher is the computational cost
and the larger is the number of parameters required to specify the force field [40]. The stud-
ies mentioned above have investigated the process of protein self-assembly in homogeneous
systems in which external factors such as nanoparticles or other molecules are absent. Only
very recently, Friedman et al. investigated the process of assembly of amphiphatic peptides
in the presence of lipid vescicles [41].
In the present work, we adopted an off-lattice protein model [42–45], in which the protein
backbone is represented as tube that embeds a chain of Cα atoms subject to interactions that
are common to all polypeptide chains, including excluded volume constraints, hydrophobic
attractions, bending rigidity, and cooperative hydrogen bonds (see Materials and Methods).
The major strength of the model is its ability to reproduce rather accurately secondary struc-
ture elements through the excluded-volume effects due to the tube geometry [42–45], which
enables the use of a relatively simple force field and thus is very efficient computationally.
By using this type of model, we already provided insight into the early stages of the aggre-
gation process, to establish the existence of a general condensation-ordering transition for
protein aggregation [46, 47], and to reveal a self-templated nucleation mechanism [48] that
is able to explain a key feature observed in protein aggregation - the coupling between the
initial formation of oligomeric assemblies and their subsequent rearrangement into a highly
ordered cross-β structures. In this work, we show the feasibility of simulating hundreds of
peptides over several milliseconds, and we characterise in detail the molecular mechanism
of self-assembly of the peptides at the surface of nanoparticles. This process takes place in
two steps - at first the peptides associate on the surface thus increasing their local concentra-
tion and subsequently they undergo a process of reordering into β sheet structures, which is
driven by the tendency to form hydrogen bonds.
Results and Discussion
Starting from the experimental observation that amyloid formation is a phenomenon com-
mon to most polypeptide chains [9], and that systems of polyamino acids have been shown to
form amyloid assemblies [49,50], we investigate the aggregation behaviour of 512 12-residue
polyamino acids in the presence of spherical nanoparticles (Fig. 1A) as a model system to
reveal the general properties of this phenomenon. The peptides that we considered exhibit
an α-helical native structure below their folding temperature T ∗f = 0.63 (expressed here in
reduced units, see Materials and Methods) and an extended random coil structure above
it. The aggregation behaviour that we observe depends on the diameter σ of the spherical
nanoparticle and on the strength of the peptide-nanoparticle interaction, eHP,S , which is the
energy gained when the distance between a Cα atom representing the peptide molecules and
the nanoparticle surface is smaller than 10A˚. This range was chosen to be similar to that of
the pairwise hydrophobic inter-residue interaction, since both interactions are effectively due
to hydrophobic solvation effects.
We first performed molecular dynamics simulations at a peptide concentration, c = 3.4mM ,
and reduced temperature, T ∗ = 0.69, at which in absence of the nanoparticle aggregation
does not occur on the timescale accessible to the simulation. At this temperature most pep-
tides are unfolded since T ∗/T ∗f = 1.1. The nanoparticle diameter is set to σ = 110A˚ and
the interaction strength between the nanoparticle and the peptides, eHP,S/eHP = 2, is set to
twice the value of the hydrophobic attraction, eHP , between different Cα atoms. The results
of a representative molecular dynamics trajectory in presence of this weakly hydrophobic
nanoparticle are shown in Fig. 1.
We consistently observe that the presence of this hydrophobic nanoparticle effectively re-
moves the lag-time prior to aggregation (Fig. 2A, red line) by triggering the condensation of
peptides on the nanoparticle surface to initially form small disordered oligomers (Fig. 1B),
which re-order into β-sheets as their size increases (Fig. 1C). Although dimers and trimers
constantly form and dissolve throughout the simulation (Fig. 2B), larger oligomers appear
only on the nanoparticle surface and at later times. For example, at t = 0.195 milliseconds,
we observed one cluster of size n = 7 in solution, and two clusters of sizes n = 7 and n = 12
on the nanoparticle surface (see Figs. 1B, 2B, middle panel). At the end of the simulation,
at t = 0.78 milliseconds, the two oligomers on the nanoparticle surface had grown to sizes
n = 36 and n = 42, whereas the oligomers in solution dissolved (see Fig. 2B, right panel). An-
imations representing the molecular dynamics trajectory corresponding to Fig. 1 (Videos S1
and S2, Supplementary Material) also illustrate that the small oligomers on the seed surface
can diffuse rather freely, and that two of them collide and merge into a larger one.
In order to provide a detailed analysis of the structure of the clusters that form on the
nanoparticle surface we calculated the liquid crystalline order parameter S = 〈3 cos2(θ) −
1/2〉, a measure for the alignment between different strands in a single β-sheet and between
different β-sheets, where θ is the angle between neighbouring peptides within an aggregat-
ing cluster. Our calculations confirm that small clusters are disordered and only larger ones
reach a value S ' 0.8 characteristic for liquid crystalline ordering (Fig. 2C). To investigate the
effect of the nanoparticle on the local structure around its surface we calculated the density
profile of peptides as a function of their distance from the centre of mass of the nanoparticle.
Our results illustrate that the presence of a hydrophobic nanoparticle leads to the formation
of a high density shell at the nanoparticle surface, which becomes more pronounced as the
simulation progresses (Fig. 2D). The enhanced density of peptides at the nanoparticle sur-
face increases the probability to form clusters, which will eventually trigger the formation
of small clusters on the seed surface. The appearance of a double layer structure seems to
be dependent on the reaching of a local density threshold (compare different curves in 2D,
rightmost panel). The facilitation of the nucleation step within an intermediate dense assem-
bly is well known in crystallisation [51] and was also observed in the assembly of peptides
into cross-β structures [47]. These results also provide a molecular illustration of the dy-
namics of polypeptide chains associated with the “corona” effect observed in recent experi-
ments [13,15], which has revealed that in vivo nanoparticles are always covered by biological
molecules.
In our simulations the lag time for nanoparticle induced peptide aggregation is about a
microsecond which is quite short compared to the lag times typically observed in experi-
ments. The latter range from some hours to several days, but it should be noted that both
peptide concentration (3.4mM ) and, especially, nanoparticle concentration (6.5µM ) are much
higher than in experiments (40− 80µM and 4− 90pM , respectively) [12]. This implies that in
our simulations nucleation barriers are essentially removed by the nanoparticle whereas in
experiments they are still high.
In our model system the binding of peptides to the nanoparticle is stronger for the more
hydrophobic surface (Fig. 2D). As a result, increasing the hydrophobicity of the nanoparticle
reduces the lag time prior to aggregation (Figs. 2A and 3). The same correlation between a
stronger nanoparticle-protein binding and a more enhanced reduction of the lag time prior
to aggregation is found in experiments on β2-microglobulin fibrillation in the presence of
hydrophobic copolymer nanoparticles [12]. This supports the already suggested notion that
a hydrophobic nanoparticle favors aggregation by leading to a local increase in peptide con-
centration around its surface. Note that, as β2-microglobulin is found to bind more weakly
to the more hydrophobic nanoparticles, the latter are found to be less effective as well in re-
ducing aggregation lag times [12]. Both these facts are not reproduced in our simulations,
reflecting our most simple modeling of the hydrophobic effect and of the internal structure
of both the nanoparticle and the protein.
We did not observe an increase of the lag time prior to aggregation by using a smaller
nanoparticle diameter, σ = 60A˚. The fluctuations in the size of the largest cluster are never-
theless larger, indicating that the bigger nanoparticle is a slightly more efficient seed. Exper-
imentally, it was shown that curvature effects can strongly affect the fibrillation kinetics in
a way which depends on solution conditions [12]. In our simulations we simply cannot ob-
serve this effect because the nucleation barriers are effectively removed by the nanoparticle.
As a final remark, we observe that the molecular mechanism associated with the con-
densation ordering transition for peptide nanoparticle association described here is indepen-
dent of particle size and hydrophobicity. The structural reorganization of protein chains in
the early disordered oligomeric assemblies from their native or unstructured conformation
to the cross-β state may be more easily observed by experiments using a nanoparticle as it
localizes the nucleation event, which may enable to monitor the reorganization process by
fluorescence methods.
Conclusions
We have characterised the process of nanoparticle-catalysed peptide aggregation in terms
of a condensation-ordering mechanism and investigated its dependence on the nanoparticle
diameter and the strength of the nanoparticle-peptide interactions. A similar mechanism of
aggregation has already been observed in the absence of catalysing factors [46–48, 52], sug-
gesting that the process of aggregation is driven in both cases by the intrinsic tendency of
polypeptide chains to associate by forming ordered networks of hydrogen bonds [53, 54].
In the case that we have studied here, the initial condensation of peptides is initiated by
nanoparticle surfaces to form small disordered oligomeric structures that subsequently re-
order into β-sheets as their size increases. Although this mechanism will be modulated by
specific sequence-dependent interactions for more complex amino acid sequences, our find-
ings are consistent with recent experiments on seeded fibrillation [12]. These results therefore
suggest that the process of protein aggregation can be speeded up by the presence of factors
capable of increasing the local concentration of proteins and thus promoting the formation of
disorder oligomeric assemblies whose presence in turn facilitates the conversion of soluble
proteins into highly ordered fibrillar structures.
Materials and Methods
Description of the model
We used a modified version of the tube model [42]. In this model, residues are represented
by their Cα atoms, which are connected into a chain with a distance of 3.8 ± 0.2A˚ between
neighbouring atoms. The tube geometry is approximated by assigning a diameter of 3.8A˚ to
the Cα atoms. Neighbouring Cα atoms are not allowed to interpenetrate. Bond angles are
restricted between 82◦ to 148◦, and an analogue of bending rigidity is introduced by means
of an energetic penalty, eS > 0, for values of bond angles lower than 107.15◦; these are the
same criteria used previously [42]. The introduction of eS is useful to mimic the constraints
placed on local conformations by the presence of side chains, as usually visualised by Ra-
machandran plot. Hydrophobicity enters through a pairwise-additive interaction energy of
eHP (positive or negative) between any pair of residues i and j > i + 2 that approach closer
than 7.5A˚.
The quasi-cylindrical symmetry of the tube is broken by the geometric requirements of
hydrogen bonds. These geometrical requirements were deduced from an analysis of 500 high
resolution PDB native structures [55], from which we computed the normalised histograms
of distances between Cα atoms involved in backbone-backbone hydrogen bonds which are
shown in Fig. 4. The distances we used to define the hydrogen bonds at the Cα atom level
are summarised in Table 1. Our definitions distinguish between hydrogen bonds that belong
to a α helix, parallel or anti-parallel β sheets. We emphasise the fact that there is not a full
correspondence with the real hydrogen bonds formed between amide and carboxyl backbone
groups. For instance, there are two different kinds of residue pairs facing each other in nearby
anti-parallel β-strands. In the first kind, the two hydrogen bonds are formed between the two
residues, whereas in the second kind, no hydrogen bond is formed between them. The two
kinds alternate along the pair of nearby strands. In our definition of hydrogen bonds based
on Cα atoms, we will say that for both kind of pairs one hydrogen bond is formed between
the two Cα’s. Yet, we keep track of the peculiar geometry of hydrogen bonds within anti-
parallel β-sheets by using two different sets of distances, which we call anti-parallel 1 and
anti-parallel 2, as the distances between consecutive Cα pairs facing each other on nearby
β-strands do indeed alternate. Furthermore, we request that one residue cannot form more
than two hydrogen bonds, and that the first and last Cα atoms of a peptide do not at all.
Hydrogen bonds may form cooperatively between residues (i, j) and (i + 1, j + 1) [or (i, j)
and (i + 1, j − 1) for anti-parallel hydrogen bonds], thereby gaining an additional energy of
0.3eHB. The distance criteria for cooperative hydrogen bonds within β-sheets are obtained
from Fig. 4F and summarised in Table 1.
The energy of hydrogen bonds was set to eHB = −3kTo, where kTo is the thermal energy
at room temperature and k is the Boltzmann constant. This energy correspond to the ex-
perimental one (1.5 kCal/mol at room temperature [56]). Values of the hydrophobicity and
stiffness parameters, eHP and eS, are given in units of kTo and the reduced temperature is
T ∗ = T/To. In all our simulations we set eS = 0.9kTo and eHP = −0.15kTo. The ratio of
a hydrogen bonding energy to hydrophobic energy is eHB/eHP = 20. As the number of hy-
drophobic contacts within an oligomer is usually about one order of magnitude larger than
the number of hydrogen bonds, our choice ensures that these interactions provide similar
contributions to the potential energy of the oligomer [47]. For this set of model parameter
the peptide folds into a native α-helical state below the folding temperature T ∗f = 0.63. eHP,S
is the parameter which determines the strength of the interaction energy between Cα atoms
representing the peptide molecules and the seed particle. The range of the peptide seed in-
teraction is set to 10A˚ from the nanoparticle surface.
Simulation techniques
We performed discontinuous molecular dynamics (DMD) simulations [57], which is a fast
alternative to standard molecular dynamics simulations. The main difference is that in DMD
simulations the system evolves on a collision by collision basis, and requires the calculation
of the collision dynamics and the search for the next collision. In the simulations we used
a cubic box, of side 633A˚, and applied periodic boundary conditions. The implementation
of our definition for the hydrogen bonding requires some additional consideration. In order
to prevent that one residue forms three hydrogen bonds we treat the associated collision as
fully elastic. In order to implement and consider cooperative hydrogen bonding we keep
and update a list of all hydrogen bonds formed in the system at all times. Note that a recal-
culation of the hydrogen bonds formed in the system without considering this list can lead
to a different result. Independent starting configurations were generated at T ∗ = 0.75 and
rapidly cooled down to T ∗ = 0.69 at the beginning of each simulation run. We performed all
our simulation in the NVT ensemble using an Anderson thermostat.
In order to associate the number of collision steps performed in our simulation to a real
time we measured the long time self-diffusion coefficient of our model peptide, Dpep =
0.0085A˚2/(collision step), and matched it to experimental data. We took from the literature
the value for the self-diffusion coefficient, Dlys = 13.7 × 10−7cm2/sec, which was measured
for lysozyme [58]. The Einstein relation for the diffusion coefficient together with the Stokes
law yieldD = κBT/6piηr whereKB is the Boltzmann constant, r is the radius of the diffusing
object, and η is the viscosity. The latter can be evaluated through kinetic theory as η ∼ nκBTτ ,
where n is the density of the viscous medium in which diffusion takes place and τ is the mean
flight time between collision with solvent molecules setting the time scale [59]. The resulting
expression for the diffusion coefficient D ∼ 1/nrτ allows us to get τlysτpep =
Dpeprpep
Dlysrlys
' 0.195
picoseconds as an estimate of the real time corresponding to one collision step in our molec-
ular dynamics simulations. We use rlys = 19A˚ as an estimate of r for lysozyme, whereas
we take rpep = 5.85A˚ as the average radius of gyration of the peptide as found in our sim-
ulations. Hence, the total number of collision steps, 4 × 109, performed in every simulation
corresponds qualitatively to 0.78 milliseconds.
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Figure 1: Illustration of the “condensation-ordering” mechanism of peptide self-assembly
in the presence of a hydrophobic nanoparticle. (A) Initially, at t = 3.9 microseconds, the
peptides are in their monomeric state. (B) At intermediate times, t = 0.195 milliseconds,
small oligomeric assemblies form on the nanoparticle surface. (C) At later times, t = 0.78
milliseconds, these oligomers re-order into fibrillar structures as their size increases. Peptides
that do not form intermolecular hydrogen bonds are shown in blue, while peptides that form
intermolecular hydrogen bonds are assigned a random colour, which is the same for peptides
that belong to the same β-sheet. Two peptides are defined as belonging to the same cluster if
their centres of mass distance is less than 5A˚. Two peptides are taken to participate within a β-
sheet if they form more than four inter-chain hydrogen bonds with each other. The spherical
nanoparticle is displayed in orange in the centre of the simulation box; the diameter of the
peptides is slightly reduced for illustration purposes. Panels (B) and (C) show enlarged views
of the nanoparticle-peptide system. The simulation was performed at c = 3.4mM , T ∗/T ∗f =
1.1, σ = 110A˚, and eHP,S/eHP = 2.
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Figure 2: Structural analysis of the nanoparticle-induced self-assembly mechanism. (A)
Average size of the largest cluster n∗ observed during a simulation in presence of a hard
sphere nanoparticle: σ = 110A˚, eHP,S = 0 (green line), and several hydrophobic nanopar-
ticles that differ in diameter and hydrophobicity: σ = 110A˚, eHP,S/eHP = 1 (blue line),
σ = 110A˚, eHP,S/eHP = 2 (red line), and σ = 65A˚, eHP,S/eHP = 2 (black line). The results are
averaged over ten independent simulation runs and the error bars correspond to the stan-
dard deviation of the mean. (B) Number of clusters Nn of size n as a function of time: t = 3.9
microseconds (left), t = 0.195 milliseconds (middle), t = 0.78 milliseconds (right), for the MD
trajectory and parameters described in Fig. 1. Black lines correspond to all clusters formed in
the system; red lines correspond to the number of clusters formed on the nanoparticle sur-
face. (C) Structural order parameter S as a function of the cluster size n averaged over ten
independent simulations. The line colours are as described in (A). (D) Normalized density
profile g(r)/g0, where g0 is the bulk density of the system, as a function of the distance from
the centre of mass of the nanoparticle at the beginning of the simulation, t = 3.9 microsec-
onds (left panel), intermediate times, t = 0.195 milliseconds (middle panel), and at the end
t = 0.78 milliseconds (right panel). The different line colours are as described in (A) and
correspond to the different seed sizes and peptide seed interaction energies. The results are
averaged over ten independent simulations and the error bars correspond to the standard
deviation of the mean.
AB
Figure 3: Illustration of the condensation-ordering mechanism for different hydrophobic-
ity of the nanoparticle, nanoparticle diameter. (A) σ = 110A˚, eHP,S/eHP = 1 at t = 3.9 mi-
croseconds(left), t = 0.165 milliseconds (middle), t = 0.78 milliseconds (right). (B) σ = 65A˚,
eHP,S/eHP = 2 at t = 3.9 microseconds (left), t = 0.195 milliseconds (middle), t = 0.78
milliseconds (right). The concentration and temperature are c = 3.4mM, T ∗/T ∗f = 1.1 respec-
tively, and the colour code is as described in Fig 1.
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Figure 4: Normalised histograms of distances between Cα atoms involved in backbone-
backbone hydrogen bonds. The analysis is based on 500 high resolution PDB structures [55]
and used to define hydrogen bonds in the protein model employed in our simulation. (A)
Histogram of distances di,j−1 and di−1,j betweenCα atoms (i, j−1) and (i−1, j) used to define
a α helical hydrogen bond assigned to atoms (i, j) with j = i+ 3. (B) Histogram of distances
di,j between Cα atoms (i, j) that form a parallel, anti-parallel, or helical hydrogen bond. For
the α helical hydrogen bond j = i + 3. (C) Illustration of the alternation of distances for
consecutive Cα atoms that form anti-parallel hydrogen bonds. (D) as in (C). (E) The distance
di,j−1 is used to define hydrogen bonds between atoms (i, j) in parallel and anti parallel β-
sheets. (F) Distances used to define cooperative hydrogen bonds between two consecutive
atoms (i, j) and (i + 1, j + 1) that form parallel β-sheets or (i, j) and (i + 1, j − 1) that form
anti parallel β-sheets.
α helix β (parallel) β (anti-parallel 1) β (anti-parallel 2) co-operativity
Cα d1 d2 Cα d1 d2 Cα d1 d2 Cα d1 d2 Cα d1 d2
(i,i+3) 4.75 5.6 (i,j) 4.3 5.5 (i,j) 3.95 4.8 (i,j) 4.9 5.7 (i-1,i+1) 5.6 7.4
(i,i+2) 5.1 5.7 (i,j-1) 5.3 6.85 (i,j-1) 4.95 6.25 (i,j-1) 5.05 6.3 (i,i+2) 5.65 7.5
(i+1,i+3) 5.2 5.75 (i-1,j) 5.2 6.95 (i-1,j) 5.0 6.4 (i-1,j) 5.1 6.5 (i-1,i+2) 9.5 10.8
(i-1,i+3) 5.8 6.7 (i+1,j+1) 4.1 5.6 (i+1,j-1) 4.7 6.0 (i+1,j-1) 3.8 5.25 (j-1,j+1) 5.6 7.4
(i-1,j-1) 4.2 5.65 (i-1,j+1) 4.75 6.1 (i-1,j+1) 3.85 5.35 (j,j+2) 5.65 7.5
(i+1,j-1) 6.15 9.9 (j-1,j+2) 9.5 10.8
Table 1: Summary of distances used to define the various hydrogen bonds. Here d1 and
d2 are the lower and the upper threshold distances obtained from Fig. 4 or from similar his-
tograms. The hydrogen bonds are formally assigned toCα atoms i, i+3 (α-helix), i, j (parallel
and anti-parallel β-sheet), and the cooperative hydrogen bonds are formed between the pairs
(i, j) and (i + 1, j + 1) for parallel β-sheets or between the pairs (i, j) and (i + 1, j − 1) for
anti-parallel β-sheets.
